BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.01 -0.01 (-50.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Short term Debt (2025 - 2026)

Updated

BioXcel Therapeutics' Short term Debt was $104.45 million in Q2 2026, up 831.3% from $11.22 million a year earlier and up 365.7% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Short term Debt at BioXcel Therapeutics came in at $24.93 million.

  • Per Business Quant data, BTAIQ's Short term Debt in the three quarters before Q2 2026 was $22.43 million (Q1 2026), $24.93 million (Q4 2025) and $16.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 BioXcel Therapeutics 409,050.01 -94.20 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104.45 Mn
Mar 31, 2026 22.43 Mn
Dec 31, 2025 24.93 Mn
Sep 30, 2025 16.82 Mn
Jun 30, 2025 11.22 Mn
Mar 31, 2025 5.61 Mn
API Access

BioXcel Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY